NRAS and neoplasm: miR-145 directly targets not only oncogene insulin receptor substrate-1 (IRS-1) but also neuroblastoma RAS viral oncogene homolog (N-RAS) and VEGF, thus significantly suppressing UM cell invasion, angiogenesis and tumor growth [62,63].